Download free PDF

HPV Testing and PAP Test Market Size & Share 2023 to 2032

Market Size by Test Type (Human Papillomavirus Testing, Co-testing, Papanicolaou Test), by Technology, (Polymerase Chain Reaction (PCR), Liquid-based Cytology, Hybrid Capture), by End Use & forecast.

Report ID: GMI3174
   |
Published Date: May 2023
 | 
Report Format: PDF

Download Free PDF

HPV Testing and PAP Test Market Size

HPV Testing and PAP Test Market size was USD 2 billion in 2022 and is poised to observe over 15.4% CAGR from 2023-2032. Rising frequency of cervical cancer to drive global industry expansion.

HPV Testing and PAP Test Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 2 Billion
  • 2032 Forecast Market Size: USD 9 Billion
  • CAGR (2023–2032): 15.4%

Key Market Drivers

  • Increasing prevalence of cervical cancer.
  • Rising number of people suffering from Human Papillomavirus (HPV).
  • Growing awareness regarding cervical cancer screening among women.
  • Surge in technological advancements regarding HPV and PAP test.

Challenges

  • Lack of reimbursement scenario.
  • Stringent regulatory framework.

HPV Testing and PAP Test Market

The surging burden of cervical cancer worldwide will increase the demand for HPV testing and PAP tests. The growing popularity of screening test kits will further influence the industry expansion. To state an instance, Roche, in 2021, received the U.S. FDA approval for the Cobas HPV test deployed for detecting the risk of cervical cancer among women by identifying the presence of high-risk human papillomavirus (HPV) DNA in cervical samples.
 

The strong presence of stringent regulatory frameworks may act as a major restraint for the industry growth. The lack of uniformity within the regulatory frameworks is giving rise to uncertainty for several firms that develop and market HPV and PAP tests given the variation of requirements and standards offered by different regulatory bodies, further delaying the product developments and market approvals. The increasing complexity of these regulations will also limit the deployment of HPV and PAP testing.
 

HPV Testing and PAP Test Market Analysis

HPV Testing and PAP Test Market Size, By Test Type

With respect to test type, the HPV testing market size is projected be worth USD 4.8 billion by 2032. The growth can be attributed to the increasing awareness regarding cervical cancer and the growing number of sexually active people. The rapidly expanding homosexual population along with the increasing number of individuals affected with weakened immune systems has stirred the higher risk of contracting HPV, subsequently amplifying the awareness regarding HPV-related illnesses.
 

HPV Testing and PAP Test Market Share, By Technology,

HPV testing and PAP test market size from the liquid-based cytology technology segment will witness over 16% CAGR from 2023-2032. Liquid-based cytology is widely employed in cervical cancer screening and includes the collection of cervical cells and their placement in liquid-based mediums for analysis. This technology is increasingly adopted in PAP tests as an alternative to traditional testing methods where cells can be directly transferred onto glass slides for examination.
 

North America HPV Testing and PAP Test Market Size

North America HPV testing and PAP test market is expected to surpass USD 3.5 billion by 2032 due to the surging healthcare expenditure in the region. The increasing awareness related to cervical cancer has made way for a large number of supportive government initiatives. The thriving need for early disease diagnosis and the subsequently rising implementation of HPV testing as well as PAP test will influence the regional industry growth.  
 

HPV Testing and PAP Test Market Share

Some of the prominent HPV testing and PAP test industry players include:

  • Hologic
  • Quest Diagnostics
  •  Abbott Laboratories
  •  Becton Dickinson & Company
  •  Onco Health Corporation
  •  Arbor Vita Corporation
  •  Femasys
  •  Qiagen N.V.
  •  Seegene
  • Mylab Discovery Solutions Pvt. Ltd.
     

HPV Testing and PAP Test Industry News

  • In February 2023, the U.S. FDA granted approval to BD’s Onclarity HPV Assay deployed along with ThinPrep PAP test for detecting HPV types 16,18, 45 as well as genotypes 31, 51, 52, 56/59/66, 33/58, and 35/39/68.
     
  • Roche Diagnostics, in June 2022, introduced a new HPV self-sampling solution in a bid to expands its cancer screening portfolio. The new solution assists patients in privately collecting the screening samples for HPV at healthcare facilities under the supervision of healthcare workers.
     

The HPV testing and PAP test market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and volume in Units from 2018 to 2032 for the following segments:

By Test type

  • Human papillomavirus (HPV) testing
  • Papanicolaou (PAP) test
  • Co-testing

By Technology

  • Polymerase chain reaction (PCR)
  • Liquid-based cytology
  • Immunodiagnostics
  • Hybrid capture
  • Others

By End-use

  • Hospitals
  • Diagnostic centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Poland
    • Switzerland
    • The Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
    • Indonesia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Columbia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel

 

Authors:  Mariam Faizullabhoy, Gauri Wani

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the size of the HPV testing and PAP test market?
Global market size for HPV testing and PAP test was USD 2 billion in 2022 and will observe 15.4% CAGR from 2023-2032 due to the increasing burden of cervical cancer worldwide.
How is liquid-based cytology driving the global market share?
HPV testing and PAP test industry size from the liquid-based cytology technology segment will witness over 16% CAGR from 2023-2032 with increasing adoption in cervical cancer screening.
What is the value of North America HPV testing and PAP test industry?
North America HPV testing and PAP test market size will surpass USD 3.5 billion by 2032 due to the surging healthcare expenditure in the region.
Which are the leading HPV testing and PAP test industry players?
Some of the well-known HPV testing and PAP test solution providers include Abbott Laboratories, Onco Health Corporation, Becton Dickinson & Company, F. Hoffmann-La Roche AG, Quest Diagnostics, Arbor Vita Corporation, Hologic, Inc., and Femasys, Inc.
HPV Testing and PAP Test Market Scope
  • HPV Testing and PAP Test Market Size

  • HPV Testing and PAP Test Market Trends

  • HPV Testing and PAP Test Market Analysis

  • HPV Testing and PAP Test Market Share

Authors:  Mariam Faizullabhoy, Gauri Wani
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 11

Tables & Figures: 253

Countries Covered: 27

Pages: 290

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)